famotidine has been researched along with Aging in 4 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine is a potent histamine H2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease." | 4.78 | Clinical pharmacokinetics of famotidine. ( Echizen, H; Ishizaki, T, 1991) |
| " Elimination half-life in the elderly patients with renal insufficiency was significantly prolonged compared to the elderly patients with normal renal function and the young volunteers." | 1.28 | Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers. ( Fujiyama, S; Imai, Y; Inotsume, N; Matsui, H; Nakano, M; Nishimura, M; Sagara, K; Sato, T, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quan, W | 1 |
| Ramirez, M | 1 |
| Taylor, C | 1 |
| Quan, F | 1 |
| Vinogradov, M | 1 |
| Walker, P | 1 |
| Murakawa, T | 1 |
| Ogasawara, E | 1 |
| Takahashi, S | 1 |
| Sugihara, K | 1 |
| Muraoka, M | 1 |
| Hirota, K | 1 |
| Hashimoto, H | 1 |
| Asai, M | 1 |
| Matsuki, A | 1 |
| Echizen, H | 1 |
| Ishizaki, T | 1 |
| Inotsume, N | 1 |
| Nishimura, M | 1 |
| Fujiyama, S | 1 |
| Sagara, K | 1 |
| Sato, T | 1 |
| Imai, Y | 1 |
| Matsui, H | 1 |
| Nakano, M | 1 |
1 review available for famotidine and Aging
| Article | Year |
|---|---|
Clinical pharmacokinetics of famotidine.
Topics: Aging; Disease; Dose-Response Relationship, Drug; Drug Interactions; Famotidine; Hemofiltration; Hum | 1991 |
2 trials available for famotidine and Aging
| Article | Year |
|---|---|
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans | 2005 |
[Does aging influence effect of pirenzepine alone or combination of pirenzepine and famotidine on gastric secretion during anesthesia and surgery?].
Topics: Adolescent; Adult; Aged; Aging; Depression, Chemical; Elective Surgical Procedures; Famotidine; Fema | 1995 |
1 other study available for famotidine and Aging
| Article | Year |
|---|---|
Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
Topics: Adult; Aged; Aging; Famotidine; Female; Half-Life; Histamine H2 Antagonists; Humans; Intestinal Abso | 1989 |